Showing results (31-40 of 155) with videos related to
Sort By:
Pageof 16
International Journal of Cancer|December 2, 1998
In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibodyK N Syrigos, G Rowlinson-Busza, A A EpenetosLeukemia & Lymphoma|September 1, 1992
Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytesC Kosmas, A A Epenetos, N S Courtenay-LuckActa Oncologica (Stockholm, Sweden)|October 24, 2001
Radioimmunoscintigraphy in patients with ovarian cancerH P Kalofonos, M V Karamouzis, A A EpenetosCell Biophysics|January 1, 1993
Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodiesC S Gooden, D E Snook, A A EpenetosCancer|June 15, 1994
Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancerC Kosmas, A A Epenetos, N S Courtenay-LuckGene Therapy|May 1, 1995
DNA vaccination for cancer treatmentR A Spooner, M P Deonarain, A A EpenetosInternational Journal of Cancer|April 12, 2002
Antibody-guided enzyme therapy of cancer producing cyanide results in necrosis of targeted cellsChristina A Kousparou, Agamemnon A Epenetos, Mahendra P DeonarainImmunology Today|December 1, 1994
Applications of monoclonal antibodies in clinical oncologyA J George, R A Spooner, A A EpenetosMabs|January 5, 2010
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?Mahendra P Deonarain, Christina A Kousparou, Agamemnon A EpenetosBritish Journal of Cancer|September 1, 1991
Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigensC Kosmas, A A Epenetos, N S Courtenay-LuckPageof 16